Cognate interaction-dependent pathogenicity of meningeal B cells drives neuroinflammation relapse
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2020YFA0804200)
- National Natural Science Foundation of China (32270923)
- National Natural Science Foundation of China (82325023)
- National Natural Science Foundation of China (32070953)
- Natural Science Foundation of Zhejiang Province (XHD23H0901)
- Center for High Performance Computing
- Westlake University
This publication has 76 references indexed in Scilit:
- ACKR1 favors transcellular over paracellular T‐cell diapedesis across the blood‐brain barrier in neuroinflammation in vitroEuropean Journal of Immunology, 2021
- Genome-wide CRISPR Screens in T Helper Cells Reveal Pervasive Crosstalk between Activation and DifferentiationCell, 2019
- Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Cell, 2019
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosisAnnals of Clinical and Translational Neurology, 2016
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosisAnnals of Neurology, 2010
- B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunityAnnals of Neurology, 2010
- Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cordsAnnals of Neurology, 2010
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple SclerosisArchives of Neurology, 2010
- Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trialAnnals of Neurology, 2008
- Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparisonMicroscopy Research and Technique, 1995